IBDEI1XT ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32860,1,4,0)
 ;;=4^Z12.2
 ;;^UTILITY(U,$J,358.3,32860,2)
 ;;=^5062684
 ;;^UTILITY(U,$J,358.3,32861,0)
 ;;=Z12.4^^128^1639^9
 ;;^UTILITY(U,$J,358.3,32861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32861,1,3,0)
 ;;=3^Screening for Malig Neop Cervix
 ;;^UTILITY(U,$J,358.3,32861,1,4,0)
 ;;=4^Z12.4
 ;;^UTILITY(U,$J,358.3,32861,2)
 ;;=^5062687
 ;;^UTILITY(U,$J,358.3,32862,0)
 ;;=Z12.12^^128^1639^12
 ;;^UTILITY(U,$J,358.3,32862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32862,1,3,0)
 ;;=3^Screening for Malig Neop Rectum
 ;;^UTILITY(U,$J,358.3,32862,1,4,0)
 ;;=4^Z12.12
 ;;^UTILITY(U,$J,358.3,32862,2)
 ;;=^5062682
 ;;^UTILITY(U,$J,358.3,32863,0)
 ;;=Z12.5^^128^1639^11
 ;;^UTILITY(U,$J,358.3,32863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32863,1,3,0)
 ;;=3^Screening for Malig Neop Prostate
 ;;^UTILITY(U,$J,358.3,32863,1,4,0)
 ;;=4^Z12.5
 ;;^UTILITY(U,$J,358.3,32863,2)
 ;;=^5062688
 ;;^UTILITY(U,$J,358.3,32864,0)
 ;;=Z12.11^^128^1639^10
 ;;^UTILITY(U,$J,358.3,32864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32864,1,3,0)
 ;;=3^Screening for Malig Neop Colon
 ;;^UTILITY(U,$J,358.3,32864,1,4,0)
 ;;=4^Z12.11
 ;;^UTILITY(U,$J,358.3,32864,2)
 ;;=^5062681
 ;;^UTILITY(U,$J,358.3,32865,0)
 ;;=Z13.1^^128^1639^4
 ;;^UTILITY(U,$J,358.3,32865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32865,1,3,0)
 ;;=3^Screening for Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,32865,1,4,0)
 ;;=4^Z13.1
 ;;^UTILITY(U,$J,358.3,32865,2)
 ;;=^5062700
 ;;^UTILITY(U,$J,358.3,32866,0)
 ;;=Z13.0^^128^1639^2
 ;;^UTILITY(U,$J,358.3,32866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32866,1,3,0)
 ;;=3^Screening for Blood/Blood-Forming Organs Diseases
 ;;^UTILITY(U,$J,358.3,32866,1,4,0)
 ;;=4^Z13.0
 ;;^UTILITY(U,$J,358.3,32866,2)
 ;;=^5062699
 ;;^UTILITY(U,$J,358.3,32867,0)
 ;;=Z13.850^^128^1639^15
 ;;^UTILITY(U,$J,358.3,32867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32867,1,3,0)
 ;;=3^Screening for TBI
 ;;^UTILITY(U,$J,358.3,32867,1,4,0)
 ;;=4^Z13.850
 ;;^UTILITY(U,$J,358.3,32867,2)
 ;;=^5062717
 ;;^UTILITY(U,$J,358.3,32868,0)
 ;;=Z13.6^^128^1639^3
 ;;^UTILITY(U,$J,358.3,32868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32868,1,3,0)
 ;;=3^Screening for Cardiovascular Disorders
 ;;^UTILITY(U,$J,358.3,32868,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,32868,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,32869,0)
 ;;=Z13.820^^128^1639^14
 ;;^UTILITY(U,$J,358.3,32869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32869,1,3,0)
 ;;=3^Screening for Osteoporosis
 ;;^UTILITY(U,$J,358.3,32869,1,4,0)
 ;;=4^Z13.820
 ;;^UTILITY(U,$J,358.3,32869,2)
 ;;=^5062713
 ;;^UTILITY(U,$J,358.3,32870,0)
 ;;=Z94.0^^128^1640^6
 ;;^UTILITY(U,$J,358.3,32870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32870,1,3,0)
 ;;=3^Kidney Transplant Status
 ;;^UTILITY(U,$J,358.3,32870,1,4,0)
 ;;=4^Z94.0
 ;;^UTILITY(U,$J,358.3,32870,2)
 ;;=^5063654
 ;;^UTILITY(U,$J,358.3,32871,0)
 ;;=Z94.1^^128^1640^4
 ;;^UTILITY(U,$J,358.3,32871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32871,1,3,0)
 ;;=3^Heart Transplant Status
 ;;^UTILITY(U,$J,358.3,32871,1,4,0)
 ;;=4^Z94.1
 ;;^UTILITY(U,$J,358.3,32871,2)
 ;;=^5063655
 ;;^UTILITY(U,$J,358.3,32872,0)
 ;;=Z95.3^^128^1640^13
 ;;^UTILITY(U,$J,358.3,32872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32872,1,3,0)
 ;;=3^Xenogenic Heart Valve Status
 ;;^UTILITY(U,$J,358.3,32872,1,4,0)
 ;;=4^Z95.3
 ;;^UTILITY(U,$J,358.3,32872,2)
 ;;=^5063671
 ;;^UTILITY(U,$J,358.3,32873,0)
 ;;=Z94.5^^128^1640^10
 ;;^UTILITY(U,$J,358.3,32873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32873,1,3,0)
 ;;=3^Skin Transplant Status
 ;;^UTILITY(U,$J,358.3,32873,1,4,0)
 ;;=4^Z94.5
